Article Details
Retrieved on: 2024-01-31 15:28:21
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
For each drug, we obtained 2022 US revenues from SSR Health and public filings (Supplementary Table 2). Using patient-level utilization data, we ...
Article found on: www.nature.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here